(Q39616884)

English

A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells

scientific article published on 22 December 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Guang-zhi Shan

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yu-huan Li

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Dong Li

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yan-ping Li

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Shuai Meng

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Lin-yan Gao

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jian-dong Jiang

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Zhuo-rong Li

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

22 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The Journal of Antibiotics

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

177-182

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Viral hepatitis in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Interferon-based therapy for chronic hepatitis C: current and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Evaluation systems for anti-HCV drugs

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

The hepatitis C virus life cycle as a target for new antiviral therapies

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Novel hepatitis C drugs in current trials

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Host cell targets in HCV therapy: novel strategy or proven practice?

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Host factors involved in the replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

Real-time RT-PCR for quantitation of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

21 January 2018

New therapies for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives

1 reference

https://api.crossref.org/works/10.1038%2FJA.2010.161

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JA.2010.161

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39616884&oldid=2203029558"